Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

London stocks end higher led by gains in energy, travel stocks; Tesco weighs

Published 14/04/2021, 08:30
Updated 14/04/2021, 17:20
© Reuters. A trading screen is seen following the opening of the markets by British Chancellor of the Exchequer Philip Hammond and Chinese Vice-Premier Hu Chunhua at  the London Stock Exchange in London

By Devik Jain and Shashank Nayar

(Reuters) -British shares ended higher on Wednesday, helped by gains in heavyweight energy and travel stocks, while Tesco (LON:TSCO) slipped to the bottom of the index after reporting a 20% drop in full-year pretax profit.

The blue-chip index rose 0.7%, with BP (LON:BP) and Royal Dutch Shell (LON:RDSa) providing upward momentum, while commodity trader Glencore (LON:GLEN) Plc was the top gainer, up 5.4% after Goldman Sachs (NYSE:GS) upgraded the stock to "buy" from "neutral".

“The FTSE 100 is still far away from its March 2020 highs, so there is good potential upside left and investors seem to be quite optimistic on UK equities as we enter the earnings season,” said Michael Baker, an analyst at ETX Capital.

However, gains were capped by Britain's biggest retailer Tesco, which tumbled 2% to the bottom of the FTSE 100, as the cost of adapting the business for the pandemic wiped out its "exceptionally strong" sales.

The blue-chip FTSE 100 has risen 7.4% this year as investors bet on a faster pace of economic recovery as businesses reopen, further aided by vaccine rollouts and government stimulus. However, a recent surge in global COVID-19 cases and concerns of higher inflation have limited gains.

The mid-cap index gained 0.4% with low-cost air carrier Easyjet giving the biggest boost, up 5.8%.

The wider travel sector gained 1.5% on hopes that the great British getaway would be possible this summer, with easyJet (LON:EZJ) predicting that most of Europe would be open for travel and British Airways confident on routes to the United States, despite ongoing uncertainty.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Drugmaker AstraZeneca (NASDAQ:AZN) Plc rose 1.5% after China's health regulator approved Tagrisso, its lung cancer treatment, as an adjuvant treatment for patients with early-stage lung cancer.

Among other stocks, Robert Walters shares jumped 6.3% after the recruiting company forecast upbeat annual profit.

Burberry Group (LON:BRBY) added 1.2% as its French rival LVMH (PA:LVMH)'s first-quarter sales bounced back far more quickly than expected.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.